Myostatin/activin pathway antagonism: Molecular basis and therapeutic potential

H.Q. Han1, Xiaolan Zhou1, William E. Mitch2, Alfred L. Goldberg3
1Metabolic Disorders Department, Amgen, Thousand Oaks, CA, USA
2Nephrology Division, Baylor College of Medicine, Houston, TX, USA
3Department of Cell Biology, Harvard Medical School, Boston, MA, USA

Tài liệu tham khảo